Publication:
Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism.

dc.contributor.authorBorges, Rosivaldo S
dc.contributor.authorPalheta, Ivanete C
dc.contributor.authorOta, Sirlene S B
dc.contributor.authorMorais, Roberto B
dc.contributor.authorBarros, Valéria A
dc.contributor.authorRamos, Ryan S
dc.contributor.authorSilva, Rai C
dc.contributor.authorCosta, Josivan da S
dc.contributor.authorSilva, Carlos H T P
dc.contributor.authorCampos, Joaquín M
dc.contributor.authorSantos, Cleydson B R
dc.date.accessioned2023-01-25T10:27:21Z
dc.date.available2023-01-25T10:27:21Z
dc.date.issued2019-01-01
dc.description.abstractA drug design for safer phenylbutazone was been explored by reactivity and docking studies involving single electron transfer mechanism, as well as toxicological predictions. Several approaches about its structural properties were performed through quantum chemistry calculations at the B3LYP level of theory, together with the 6-31+G(d,p) basis sets. Molecular orbital and ionization potential were associated to electron donation capacity. The spin densities contribution showed a preferential hydroxylation at the para-positions of phenyl ring when compared to other positions. In addition, on electron abstractions the aromatic hydroxylation has more impact than alkyl hydroxylation. Docking studies indicate that six structures 1, 7, 8 and 13⁻15 have potential for inhibiting human as well as murine COX-2, due to regions showing similar intermolecular interactions to the observed for the control compounds (indomethacin and refecoxib). Toxicity can be related to aromatic hydroxylation. In accordance to our calculations, the derivatives here proposed are potentially more active as well safer than phenylbutazone and only structures 8 and 13⁻15 were the most promising. Such results can explain the biological properties of phenylbutazone and support the design of potentially safer candidates.
dc.identifier.doi10.3390/molecules24010143
dc.identifier.essn1420-3049
dc.identifier.pmcPMC6337259
dc.identifier.pmid30609687
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337259/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/1420-3049/24/1/143/pdf?version=1546340596
dc.identifier.urihttp://hdl.handle.net/10668/13375
dc.issue.number1
dc.journal.titleMolecules (Basel, Switzerland)
dc.journal.titleabbreviationMolecules
dc.language.isoen
dc.organizationIBS
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectDFT
dc.subjectelectron transfer
dc.subjectmetabolism
dc.subjectphenylbutazone
dc.subjecttoxicity
dc.subject.meshDrug Discovery
dc.subject.meshHumans
dc.subject.meshHydrophobic and Hydrophilic Interactions
dc.subject.meshModels, Molecular
dc.subject.meshMolecular Conformation
dc.subject.meshMolecular Structure
dc.subject.meshPhenylbutazone
dc.subject.meshStructure-Activity Relationship
dc.titleToward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number24
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC6337259.pdf
Size:
2.18 MB
Format:
Adobe Portable Document Format